Aytu BioPharma, Inc. (NASDAQ:AYTU) Q3 2025 Earnings Call Transcript May 14, 2025
Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $0.2, expectations were $-0.17.
Operator: Greetings. And welcome to the Aytu BioPharma Fiscal 2025 Q3 Earnings Call. At this time, all participants are in a listen-only. [Operator Instructions] Please note, this conference is being recorded. I’ll now turn the conference over to your host, Robert Blum, Investor Relations at Aytu. Robert, your...
